<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02241967</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN-005-13F</org_study_id>
    <secondary_id>CX001078</secondary_id>
    <nct_id>NCT02241967</nct_id>
  </id_info>
  <brief_title>Dose Dependent Effects of tDCS on Post-Operative Pain</brief_title>
  <acronym>tDCS-TKA</acronym>
  <official_title>Dose Dependent Effects of tDCS on Post-Operative Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proper control of acute and chronic pain is one of the most important areas in health&#xD;
      care. Despite the profound advances in neuroscience over the past 20 years, the investigators&#xD;
      still largely use opiate narcotics, much as was done in the Civil War. Total knee&#xD;
      arthroplasty (TKA) is one of the most common orthopedic procedures performed 1. While knee&#xD;
      pain is often a complaint that precedes TKA, the procedure itself is associated with&#xD;
      considerable post-operative pain lasting days to weeks. Adequate postoperative pain control&#xD;
      is an important factor in determining recovery time and hospital length of stay. New&#xD;
      analgesic strategies are needed that can be used adjunctively to existing strategies with the&#xD;
      potential to reduce reliance on opioid analgesia. Several novel brain stimulation&#xD;
      technologies including transcranial magnetic stimulation (TMS) and transcranial direct&#xD;
      current stimulation (tDCS) are beginning to demonstrate promise as treatments for a variety&#xD;
      of pain conditions. Electricity has no metabolite or other residue, and can be delivered with&#xD;
      minimal discomfort and without problems associated with drug-drug interactions. In two&#xD;
      independent preliminary pilot studies, the Investigators have shown that tDCS can reduce&#xD;
      post-operative PCA use by as much as 46% while simultaneously reducing subjective pain&#xD;
      ratings. The present study aims to determine the effects of transcranial direct current&#xD;
      stimulation (tDCS) on post-operative pain, patient-controlled analgesia (PCA) use, and&#xD;
      post-surgical complications during the 48-hour post-operative period following total knee&#xD;
      arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study employs a randomized, double-blind, sham-controlled design to evaluate the&#xD;
      effects of tDCS on pain among Veterans receiving unilateral total knee arthroplasty (TKA) and&#xD;
      unilateral total hip arthroplasty (THA). Further, this study will examine dose-dependency of&#xD;
      the tDCS analgesic effects. Each tDCS session delivered either 20 min of real or sham tDCS.&#xD;
      Real tDCS was administered at 2mA whereas sham tDCS delivered none.&#xD;
&#xD;
      120 patients undergoing TKA will be randomly assigned to one of four groups:Group 1 will have&#xD;
      4 sessions of real tDCS, Group 2 - 2 sessions of real tDCS (+ 2 sham-sessions), and Group 3 -&#xD;
      1 session of real tDCS (+ 3 sham-sessions). Group 4 is &quot;Sham&quot; tDCS, which does not involve&#xD;
      any real stimulation. The participants will receive 2 tDCS treatments on the day of their&#xD;
      surgery, and 2 tDCS treatments the day after their surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2016</start_date>
  <completion_date type="Actual">July 2, 2020</completion_date>
  <primary_completion_date type="Actual">July 2, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative Opioid Pain Medication Dose</measure>
    <time_frame>2-Days</time_frame>
    <description>Patient Controlled Analgesia pump usage will be measured (mg of morphine-equivalent) during the acute post-operative period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-reported Pain Intensity Ratings</measure>
    <time_frame>2-Days</time_frame>
    <description>Patients reported pain intensity using a visual analog scale (VAS) before and after each tDCS session during the 2 day routine postoperative hospital stay. Patients reported pain intensity by marking a line anchored with &quot;0- no pain at all&quot; to &quot;10- worst pain imaginable.&quot; This outcome data is the sum of all VAS scores collected before and after each tDCS session during the 2-day hospital stay, thus each participant had a total of 8 VAS scores during the experimental intervention during hospital stay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Pain Ratings</measure>
    <time_frame>6 Months</time_frame>
    <description>Visual analogue scale pain ratings will be collected during the perioperative and post-discharge periods . Visual analogue scale ratings range from 0-10; a blank line is anchored with a 0 and 10 with the following labels: &quot;0- no pain,&quot; &quot;10-worst pain imaginable.&quot;</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">119</enrollment>
  <condition>Total Knee Arthroplasty (Postoperative Pain)</condition>
  <condition>Total Hip Arthroplasty(Postoperative Pain)</condition>
  <arm_group>
    <arm_group_label>tDCS Full Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 active treatments</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS Half Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 active treatments</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS Minimal dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 active treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>no active treatments</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>4 Real sessions of Transcranial Direct Current Stimulation</intervention_name>
    <description>Stimulation of brain areas associated with pain perception using low amplitude direct current of 2mA delivered by electrodes attached to the scalp.</description>
    <arm_group_label>tDCS Full Dose</arm_group_label>
    <other_name>tDCS Full Dose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2 Real Sessions of Transcranial Direct Current Stimulation</intervention_name>
    <description>Stimulation of brain areas associated with pain perception using low amplitude direct current of 2mA delivered by electrodes attached to the scalp. 2 real sessions of tDCS and 2 sham.</description>
    <arm_group_label>tDCS Half Dose</arm_group_label>
    <other_name>tDCS Half Dose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>1 Real Session of Transcranial Direct Current Stimulation</intervention_name>
    <description>Stimulation of brain areas associated with pain perception using low amplitude direct current of 2mA delivered by electrodes attached to the scalp. 1 real sessions of tDCS and 3 sham.</description>
    <arm_group_label>tDCS Minimal dose</arm_group_label>
    <other_name>tDCS Minimal Dose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Transcranial Direct Current Stimulation</intervention_name>
    <description>Four sessions of sham tDCS; control intervention.</description>
    <arm_group_label>Sham tDCS</arm_group_label>
    <other_name>Sham tDCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Participants will be 120 patients undergoing TKA or THA surgery at the Ralph H. Johnson&#xD;
        VAMC in Charleston SC.&#xD;
&#xD;
          -  Between the ages of 19 and 90&#xD;
&#xD;
          -  Mentally capable of reading, writing, giving consent, and following instructions&#xD;
&#xD;
          -  Cleared for and scheduled for unilateral TKA or THA surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Implanted medical devices above the waist&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  History of seizures&#xD;
&#xD;
          -  Allergic to latex rubber&#xD;
&#xD;
          -  Psychiatric conditions other than for depression and/or anxiety disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey J Borckardt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ralph H. Johnson VA Medical Center, Charleston, SC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ralph H. Johnson VA Medical Center, Charleston, SC</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401-5799</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 2, 2014</study_first_submitted>
  <study_first_submitted_qc>September 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2014</study_first_posted>
  <results_first_submitted>June 25, 2021</results_first_submitted>
  <results_first_submitted_qc>September 10, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 7, 2021</results_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>pain</keyword>
  <keyword>post-surgical pain</keyword>
  <keyword>opioid</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>tDCS</keyword>
  <keyword>brain stimulation</keyword>
  <keyword>total hip arthroplasty</keyword>
  <keyword>TKA</keyword>
  <keyword>THA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 8, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/67/NCT02241967/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>tDCS Full Dose</title>
          <description>4 active treatments administered at 2mA for 20minutes each sessions, two the day of surgery and two the day after surgery.&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="P2">
          <title>tDCS Half Dose</title>
          <description>2 active treatments administered at 2mA for 20minutes each sessions. 2 real sessions the day of surgery and 2 sham sessions the day after surgery.&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="P3">
          <title>tDCS Minimal Dose</title>
          <description>1 active treatment administered at 2mA for 20minutes for the first session immediately following surgery, then 1 sham session later, day of surgery, and 2 sham sessions the day after surgery.&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="P4">
          <title>Sham tDCS</title>
          <description>no active treatments. All 4 sessions were sham tDCS. 2 delivered day of surgery, 2 delivered day after surgery.&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>tDCS Full Dose</title>
          <description>4 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="B2">
          <title>tDCS Half Dose</title>
          <description>2 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="B3">
          <title>tDCS Minimal Dose</title>
          <description>1 active treatment&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="B4">
          <title>Sham tDCS</title>
          <description>no active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="29"/>
            <count group_id="B5" value="119"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.9" spread="8.73"/>
                    <measurement group_id="B2" value="67.0" spread="8.95"/>
                    <measurement group_id="B3" value="63.5" spread="7.93"/>
                    <measurement group_id="B4" value="64.2" spread="8.14"/>
                    <measurement group_id="B5" value="64.7" spread="8.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="28"/>
                    <measurement group_id="B5" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="28"/>
                    <measurement group_id="B5" value="116"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="82"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="29"/>
                    <measurement group_id="B5" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Procedure Type</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Total Knee Arthroplasty (TKA)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="82"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Total Hip Arthroplasty (THA)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post-operative Opioid Pain Medication Dose</title>
        <description>Patient Controlled Analgesia pump usage will be measured (mg of morphine-equivalent) during the acute post-operative period.</description>
        <time_frame>2-Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>tDCS Full Dose</title>
            <description>4 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
          <group group_id="O2">
            <title>tDCS Half Dose</title>
            <description>2 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
          <group group_id="O3">
            <title>tDCS Minimal Dose</title>
            <description>1 active treatment&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
          <group group_id="O4">
            <title>Sham tDCS</title>
            <description>no active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Opioid Pain Medication Dose</title>
          <description>Patient Controlled Analgesia pump usage will be measured (mg of morphine-equivalent) during the acute post-operative period.</description>
          <units>mg of morphine equivalent dose (MED)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.99" spread="2.99"/>
                    <measurement group_id="O2" value="31.12" spread="3.73"/>
                    <measurement group_id="O3" value="28.65" spread="31.12"/>
                    <measurement group_id="O4" value="33.15" spread="5.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient-reported Pain Intensity Ratings</title>
        <description>Patients reported pain intensity using a visual analog scale (VAS) before and after each tDCS session during the 2 day routine postoperative hospital stay. Patients reported pain intensity by marking a line anchored with &quot;0- no pain at all&quot; to &quot;10- worst pain imaginable.&quot; This outcome data is the sum of all VAS scores collected before and after each tDCS session during the 2-day hospital stay, thus each participant had a total of 8 VAS scores during the experimental intervention during hospital stay.</description>
        <time_frame>2-Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>tDCS Full Dose</title>
            <description>4 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
          <group group_id="O2">
            <title>tDCS Half Dose</title>
            <description>2 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
          <group group_id="O3">
            <title>tDCS Minimal Dose</title>
            <description>1 active treatment&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
          <group group_id="O4">
            <title>Sham tDCS</title>
            <description>no active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-reported Pain Intensity Ratings</title>
          <description>Patients reported pain intensity using a visual analog scale (VAS) before and after each tDCS session during the 2 day routine postoperative hospital stay. Patients reported pain intensity by marking a line anchored with &quot;0- no pain at all&quot; to &quot;10- worst pain imaginable.&quot; This outcome data is the sum of all VAS scores collected before and after each tDCS session during the 2-day hospital stay, thus each participant had a total of 8 VAS scores during the experimental intervention during hospital stay.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="28"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.33" spread=".44"/>
                    <measurement group_id="O2" value="5.59" spread=".43"/>
                    <measurement group_id="O3" value="5.84" spread=".48"/>
                    <measurement group_id="O4" value="5.33" spread=".56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-reported Pain Ratings</title>
        <description>Visual analogue scale pain ratings will be collected during the perioperative and post-discharge periods . Visual analogue scale ratings range from 0-10; a blank line is anchored with a 0 and 10 with the following labels: &quot;0- no pain,&quot; &quot;10-worst pain imaginable.&quot;</description>
        <time_frame>6 Months</time_frame>
        <posting_date>07/2022</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2-Days during the routine post-operative hospital stay; the duration in which tDCS was delivered.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>tDCS Full Dose</title>
          <description>4 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="E2">
          <title>tDCS Half Dose</title>
          <description>2 active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="E3">
          <title>tDCS Minimal Dose</title>
          <description>1 active treatment&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
        <group group_id="E4">
          <title>Sham tDCS</title>
          <description>no active treatments&#xD;
Transcranial Direct Current Stimulation: Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeffrey Borckardt, Ph.D</name_or_title>
      <organization>Ralph H. Johnson VA Medical Center</organization>
      <phone>843-792-3295</phone>
      <email>Jeffrey.Borckardt@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

